Newey, A., Griffiths, B., Michaux, J., Pak, H. S., Stevenson, B. J., Woolston, A., . . . Gerlinger, M. (2019). Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment. J Immunother Cancer.
Čikaški stil citiranjaNewey, Alice, et al. "Immunopeptidomics of Colorectal Cancer Organoids Reveals a Sparse HLA Class I Neoantigen Landscape and No Increase in Neoantigens With Interferon or MEK-inhibitor Treatment." J Immunother Cancer 2019.
MLA način citiranjaNewey, Alice, et al. "Immunopeptidomics of Colorectal Cancer Organoids Reveals a Sparse HLA Class I Neoantigen Landscape and No Increase in Neoantigens With Interferon or MEK-inhibitor Treatment." J Immunother Cancer 2019.